Literature DB >> 22714899

Magnesium sulfate treatment decreases the initial brain damage alterations produced after perinatal asphyxia in fetal lambs.

Felipe Goñi-de-Cerio1, Antonia Alvarez, Idoia Lara-Celador, Francisco J Alvarez, Daniel Alonso-Alconada, Enrique Hilario.   

Abstract

The aim of this work was to analyze the effect of MgSO(4) treatment in the brain after hypoxic-ischemic (HI) injury in premature fetal lambs. Injury was induced by partial occlusion of umbilical cord for 60 min, and then the preterm lambs (80-90% of gestation) were randomly assigned to one of the following groups: control group, in which the animals were managed by conventional mechanical ventilation for 3 hr; 3 hr postpartial cord occlusion (3-hr-PCO) group, in which injured animals were managed by ventilation and then sacrificed 3 hr after HI; and MgSO(4) group, in which animals received 400 mg/kg MgSO(4) for 20 min soon after HI was induced and were managed by ventilation for 3 hr. Brains were analyzed for apoptosis by TUNEL assay. Cell viability and intracellular state studies were assessed by flow cytometry. The delayed death index was significantly increased in the 3-hr-PCO group in comparison with control. Administration of MgSO(4) elicited a delay in cell death that was similar to that in the control group. The 3-hr-PCO group showed a significantly higher concentration of reactive oxygen species, mitochondrial damage, and intracellular calcium in comparison with control and MgSO(4) - treated groups. Our results suggest that MgSO(4) treatment might have potential therapeutic benefits after the HI event.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22714899     DOI: 10.1002/jnr.23091

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  6 in total

1.  Chronic dietary magnesium-L-threonate speeds extinction and reduces spontaneous recovery of a conditioned taste aversion.

Authors:  G Andrew Mickley; Nita Hoxha; Joseph L Luchsinger; Morgan M Rogers; Nathanael R Wiles
Journal:  Pharmacol Biochem Behav       Date:  2013-03-06       Impact factor: 3.533

2.  Neonatal Magnesium Levels Between 24 and 48 Hours of Life and Outcomes for Epilepsy and Motor Impairment in Premature Infants.

Authors:  Betsy Ostrander; Tyler Bardsley; Ernest Kent Korgenski; Tom Greene; Joshua L Bonkowsky
Journal:  Pediatr Neurol       Date:  2016-03-03       Impact factor: 3.372

3.  Neonatal magnesium levels correlate with motor outcomes in premature infants: a long-term retrospective cohort study.

Authors:  Elizabeth Doll; Jacob Wilkes; Lawrence J Cook; E Kent Korgenski; Roger G Faix; Bradley A Yoder; Rajendu Srivastava; Catherine M T Sherwin; Michael G Spigarelli; Erin A S Clark; Joshua L Bonkowsky
Journal:  Front Pediatr       Date:  2014-11-05       Impact factor: 3.418

4.  Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury.

Authors:  I Lara-Celador; F Goñi-de-Cerio; Antonia Alvarez; Enrique Hilario
Journal:  Neural Regen Res       Date:  2013-03-15       Impact factor: 5.135

5.  Magnesium sulfate treatment for juvenile ferrets following induction of hydrocephalus with kaolin.

Authors:  Domenico L Di Curzio; Emily Turner-Brannen; Xiaoyan Mao; Marc R Del Bigio
Journal:  Fluids Barriers CNS       Date:  2016-04-27

6.  A Systematic Review of Magnesium Sulfate for Perinatal Neuroprotection: What Have We Learnt From the Past Decade?

Authors:  Robert Galinsky; Justin M Dean; Ingran Lingam; Nicola J Robertson; Carina Mallard; Laura Bennet; Alistair J Gunn
Journal:  Front Neurol       Date:  2020-05-27       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.